SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-103771
Filing Date
2022-09-28
Accepted
2022-09-28 17:26:51
Documents
1
Period of Report
2022-10-24

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2226828d1_pre14a.htm PRE 14A 330682
  Complete submission text file 0001104659-22-103771.txt   331660
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: PRE 14A | Act: 34 | File No.: 001-39650 | Film No.: 221277088
SIC: 6770 Blank Checks